235 related articles for article (PubMed ID: 21837655)
21. Hepatosplenic T-Cell Lymphoma in an Immunocompetent Male with Central Nervous System Invasion: A Rare Clinical Entity.
Wu F; Pan Y; Wang H; Tao Q; An F; Zhang J; Zhai Z
Cytometry B Clin Cytom; 2019 Nov; 96(6):475-479. PubMed ID: 30500103
[TBL] [Abstract][Full Text] [Related]
22. Primary lymphoma of the spleen. Report of a case with diagnosis by fine-needle guided biopsy.
Cavanna L; Artioli F; Vallisa D; Di Donato C; Bertè R; Carapezzi C; Foroni R; Del Vecchio C; Lo Monaco B; Prati R
Haematologica; 1995; 80(3):241-3. PubMed ID: 7672717
[TBL] [Abstract][Full Text] [Related]
23. Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma?
Ok CY; Yin CC; Yabe M; Bueso-Ramos CE; Miranda RN; Medeiros LJ; Konoplev SN
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):e95-e100. PubMed ID: 24524924
[No Abstract] [Full Text] [Related]
24. Histopathological, immunophenotypic and clinical particularities and evolution of a case of hepatosplenic T-cell lymphoma in transformation to leukemia.
Benedek Lázár E; Köpeczi JB; Tunyogi AB; Kakucs E; Horváth E; Turcu M; Benedek I
Rom J Morphol Embryol; 2013; 54(4):1135-9. PubMed ID: 24399013
[TBL] [Abstract][Full Text] [Related]
25. Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis.
Yabe M; Medeiros LJ; Wang SA; Tang G; Bueso-Ramos CE; Jorgensen JL; Bhagat G; Chen W; Li S; Young KH; Miranda RN
Am J Surg Pathol; 2017 Jan; 41(1):82-93. PubMed ID: 27755009
[TBL] [Abstract][Full Text] [Related]
26. Leukemic phase of hepatosplenic T-cell lymphoma: A great masquerader of acute leukemia.
Sharma S; Sreedharanunni S; Sachdeva MUS; Prakash G; Varma N
Indian J Pathol Microbiol; 2017; 60(3):437-438. PubMed ID: 28937394
[No Abstract] [Full Text] [Related]
27. Leukemic conversion of hepatosplenic T-cell lymphoma with pleomorphic morphology and an aggressive course.
Sharma P; Nampoothiri RV; Sharma P; Naseem S; Malhotra P; Varma N
Indian J Pathol Microbiol; 2018; 61(2):292-293. PubMed ID: 29676383
[No Abstract] [Full Text] [Related]
28. Cutaneous presentation of hepatosplenic T-cell lymphoma-a potential mimicker of primary cutaneous gamma-delta T-cell lymphoma.
Karpate A; Barcena C; Hohl D; Bisig B; de Leval L
Virchows Arch; 2016 Nov; 469(5):591-596. PubMed ID: 27562705
[No Abstract] [Full Text] [Related]
29. Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Review With an Emphasis on Diagnostic Differentiation From Other T-Cell/Natural Killer-Cell Neoplasms.
Shi Y; Wang E
Arch Pathol Lab Med; 2015 Sep; 139(9):1173-80. PubMed ID: 26317456
[TBL] [Abstract][Full Text] [Related]
30. Fulminant liver failure induced by hepatosplenic alphabeta T-cell lymphoma.
Petersen-Benz C; Hoffmann N; Beckurts T; Goeser T; Steffen HM; Dries V
Z Gastroenterol; 2003 Nov; 41(11):1083-6. PubMed ID: 14648377
[TBL] [Abstract][Full Text] [Related]
31. Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy.
van de Meeberg MM; Derikx LA; Sinnige HA; Nooijen P; Schipper DL; Nissen LH
World J Gastroenterol; 2016 Dec; 22(47):10465-10470. PubMed ID: 28058028
[TBL] [Abstract][Full Text] [Related]
32. Coexistent hairy cell leukaemia and hepatosplenic T-cell lymphoma: a case report.
Gasljevic G; Kloboves-Prevodnik V; Gazic B; Vovk M
Diagn Pathol; 2014 Mar; 9():58. PubMed ID: 24621139
[TBL] [Abstract][Full Text] [Related]
33. Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks?
Subramaniam K; Yeung D; Grimpen F; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J
Intern Med J; 2014 Mar; 44(3):287-90. PubMed ID: 24621284
[TBL] [Abstract][Full Text] [Related]
34. De novo CD3 negative hepatosplenic T-cell lymphoma: diagnostic challenges and pitfalls.
Kapur LH; Khaled Y; Solh M; Ward D; Chang CC
Arch Pathol Lab Med; 2014 Jul; 138(7):969-73. PubMed ID: 24978925
[TBL] [Abstract][Full Text] [Related]
35. Development of hepatosplenic gammadelta T-cell lymphoma with pancytopenia during early pregnancy: a case report and review of the literature.
Niitsu N; Kohri M; Togano T; Nakamine H; Nakamura S; Iwabuchi K; Higashihara M
Eur J Haematol; 2004 Nov; 73(5):367-71. PubMed ID: 15458516
[TBL] [Abstract][Full Text] [Related]
36. [Dermatomyositis associated with hepatosplenic gamma delta T-cell lymphoma].
Chandesris MO; Crétel-Durand E; Jean R; Rey J; Figarella-Branger D; Sainty D; Durand JM
Rev Med Interne; 2007 Aug; 28(8):552-5. PubMed ID: 17559983
[TBL] [Abstract][Full Text] [Related]
37. Hepatosplenic gamma-delta T-cell lymphoma associated with Epstein-Barr virus.
Tsunematsu S; Natsuizaka M; Fujita H; Otsuka N; Terashita K; Sato F; Kobayashi T; Nakai M; Tsukuda Y; Horimoto H; Sho T; Suda G; Nakanishi M; Hashino S; Chuma M; Sakamoto N
Intern Med; 2014; 53(18):2079-82. PubMed ID: 25224191
[TBL] [Abstract][Full Text] [Related]
38. [Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report].
Kalac M; Ostojić S; Gasparov S; Planinc-Peraica A; Dominis M; Jaksić B
Lijec Vjesn; 2006; 128(3-4):76-8. PubMed ID: 16808095
[TBL] [Abstract][Full Text] [Related]
39. NK-cell-associated receptor expression in hepatosplenic T-cell lymphoma, insights into pathogenesis.
Morice WG; Macon WR; Dogan A; Hanson CA; Kurtin PJ
Leukemia; 2006 May; 20(5):883-6. PubMed ID: 16525496
[No Abstract] [Full Text] [Related]
40. [Hepatosplenic gammadeltaT-cell lymphoma: a clinicopathological study].
Geng J; Zhu MG; Ding YQ; Han HX
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):88-90. PubMed ID: 14724108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
